Alpha Lipoic Acid References

  1. Higdon, Jane. "Linus Pauling Institute at Oregon State University: Micronutrient Information Center: Lipoic Acid". http://lpi.oregonstate.edu/infocenter/othernuts/la/index.html#food_source. Retrieved 2007-04-06.
  2. "Treating Type 2 Diabetes with Dietary Supplements". http://nccam.nih.gov/health/diabetes/#alpha. Retrieved 2007-04-06.
  3. Berkson, BM. “Thioctic Acid in the Treatment of Poisoning with Alpha amanitin.” Amanita Toxins and Poisonings, 1980. Amanita Toxins and Poisonings, 203 (Heidelberg: International Amanita Symposium, Nov. 1-3, 1978). eds Faulstich, H., Kommerell, B., and Th. Wieland, Verlag Gerhard Witzstrock, Baden-Baden, Koln, New York 1980.
  4. Berkson, B. 1979. Thioctic acid in treatment of hepatotoxic mushroom poisoning (letter). New England Journal of Medicine. 300:371.
  5. Bartter FC, Berkson BM, Gallelli J and Hiranaka P. “Treatment of Four Delayed-Mushroom-Poisoning Patients with Thioctic Acid.” in Amanita Toxins and Poisonings, eds Faulstich, H., Kommerell, B., and T.Wieland, Verlag Gerhard Witzstrock, Baden-Baden, New York 1980.
  6. Cremer DR Rabeler R Roberts A Lynch B (2006). "-term safety of alpha-lipoic acid (ALA) consumption: A 2-year study". Long Regul Toxicol Pharmacol 46: 193–201. doi:10.1016/j.yrtph.2006.06.003.
  7. Cause of a treatable peripheral neuropathy John J. Halperin, MD, Brian W. Little, MD, PhD, Patricia K. Coyle, MD and Raymond J. Dattwyler, MD NEUROLOGY 1987;37:1700.
  8. Ziegler D, Ametov A, Barinov A, Dyck PJ, Gurieva I, Low PA, Munzel U, Yakhno N, Raz I, Novosadova M, Maus J, Samigullin Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. R.Diabetes Care. 2006 Nov;29(11):2365-70.
  9. Takeuchi Y, Miyamoto T, Kakizawa T, Shigematsu S, Hashizume K. Insulin Autoimmune Syndrome possibly caused by alpha lipoic acid. Intern Med. 46.5 (2007): 237-239.
  10. Jacob S, Henriksen EJ, Tritschler HJ, et al. Improvement of insulin-stimulated glucose-disposal in type 2 diabetes after repeated parenteral administration of thioctic acid. Exp Clin Endocrinol Diabetes 1996;104:284-288. 
  11. Carreau JP. Biosynthesis of lipoic acid via unsaturated fatty acids. Methods Enzymol. 1979;62:152-158.
  12. Smith AR, Shenvi SV, Widlansky M, Suh JH, Hagen TM. Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress. Curr Med Chem. 2004;11(9):1135-1146.
  13. Hermann R, Niebch G, Borbe HO, et al. Enantioselective pharmacokinetics and bioavailability of different racemic alpha-lipoic acid formulations in healthy volunteers. Eur J Pharm Sci. 1996;4:167-174. 
  14. Teichert J, Hermann R, Ruus P, Preiss R. Plasma kinetics, metabolism, and urinary excretion of alpha-lipoic acid following oral administration in healthy volunteers. J Clin Pharmacol. 2003;43(11):1257-1267.